How big is the US Diabetes Drugs And Devices Market?

The US Diabetes Drugs And Devices Market size is expected to reach USD 60.12 billion in 2024 and grow at a CAGR of greater than 4% to reach USD 70.24 billion by 2029. Read More

What is the current US Diabetes Drugs And Devices Market size?

In 2024, the US Diabetes Drugs And Devices Market size is expected to reach USD 60.12 billion. Read More

Who are the key players in US Diabetes Drugs And Devices Market?

Medtronics, Roche, NovoNordisk, Sanofi and Omnipod are the major companies operating in the US Diabetes Drugs And Devices Market. Read More

What years does this US Diabetes Drugs And Devices Market cover, and what was the market size in 2023?

In 2023, the US Diabetes Drugs And Devices Market size was estimated at USD 57.72 billion. The report covers the US Diabetes Drugs And Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the US Diabetes Drugs And Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

US Diabetes Drugs And Devices Market Share

Statistics for the 2023 & 2024 US Diabetes Drugs And Devices market share, created by Mordor Intelligence™ Industry Reports. US Diabetes Drugs And Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of US Diabetes Drugs And Devices Industry

Manufacturers have constantly innovated to survive in the market. Large companies such as Abbott and Medtronic have made numerous mergers, acquisitions, and partnerships to gain market dominance while adhering to organic growth strategies. The manufacturers of insulin delivery devices are spending a huge amount on the R&D of the devices.